We are looking for an experienced and collaborative Senior Scientist to join the ADMET-MetID team within Orion Pharma R&D in Turku. In this role, you will provide scientific leadership in early toxicology and support the development of human-relevant safety assessment activities.
Your role
As a Senior Scientist, you will:
This is a permanent, full-time, on-site position based in Turku, Finland. In this role, you will report to Head of ADMET & MetID.
What we offer
At Orion Pharma, you will have the opportunity to contribute to the development of future therapies that improve patients' lives. We offer meaningful and challenging work within an innovative R&D environment, together with excellent opportunities for professional growth and career development.
Our culture is based on collaboration, continuous improvement, and appreciation of our people. Orion R&D offers an informal and supportive working environment where we enjoy working and succeeding together.
Please visit our website to find further information about our values and Orion as an employer https://www.orion.fi/en/careers/orion-as-an-employer/.
What we are looking for
To succeed in this role, you have:
Experience in one or more of the following areas is considered a strong advantage:
How to apply
If you are interested in this opportunity, please submit your application by September 28, 2026. We may begin interviewing candidates during the application period. We kindly ask recruitment agencies and headhunters not to contact us regarding this vacancy.
For further information about the position, please contact: Satu-Maarit Heinonen, Head of ADMET-MetID, Tel. +358 50 966 2060. Contact times: September 14th and September 21st, between 14:00-15:00 EEST.
Approved medical examination which also includes drug testing is required prior to the employment. We will also carry out a security clearance prior to the employment for the selected person.
#LI-ORION
Your new team
Orion’s pharmaceutical innovations are created within its R&D organization. We employ over 400 top professionals in the field of drug discovery and development. We work globally: in Espoo and Turku in Finland, in Nottingham and Cambridge in the UK, and in Cambridge, MA, USA. Orion R&D and the Innovative Medicines business division are dedicated to making a transformation to become a global player in the pain and oncology therapy areas.
The ADMET-MetID unit is part of Integrated DMPK and Safety within Orion R&D. We are responsible for early ADME and early safety assessment of new drug candidates. Our team provides in vitro ADME and toxicology services and scientific expertise throughout the drug discovery and development process, supporting Orion's key therapeutic areas, Oncology and Pain. You will join a multidisciplinary team of experienced scientists and research associates located in both Espoo and Turku.
Orion Pharma is a globally operating Nordic pharmaceutical company – a builder of well-being for over a hundred years.
We’re home to more than 4,000 Orionees around the world, and we’re proud to be known as a responsible employer and a great place to work. At Orion Pharma, people are truly valued and trusted, encouraged to grow, and supported by a culture where every voice is heard. We appreciate each other, strive for excellence, and build the future.
Together we develop, manufacture, and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines as well as consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain. Proprietary products developed by Orion Pharma are used to treat cancer, neurological diseases, respiratory diseases, and more.
We offer careers with a clear purpose: empowering people to live their lives to the fullest.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
Orion is a company that operates a career site, likely for recruitment purposes.